Terms: = Kidney tumors AND RAC1, ENSG00000136238, 5879, MIG5, MGC111543, P63000, p21-Rac1, TC-25 AND Treatment
11 results:
1. Ketorolac modulates Rac-1/HIF-1α/DDX3/β-catenin signalling via a tumor suppressor prostate apoptosis response-4 (Par-4) in renal cell carcinoma.
Sonawane V; Ghosalkar J; Achrekar S; Joshi K
Sci Rep; 2023 Apr; 13(1):5659. PubMed ID: 37024613
[TBL] [Abstract] [Full Text] [Related]
2. DOCK6 promotes chemo- and radioresistance of gastric cancer by modulating WNT/β-catenin signaling and cancer stem cell traits.
Chi HC; Tsai CY; Wang CS; Yang HY; Lo CH; Wang WJ; Lee KF; Lai LY; Hong JH; Chang YF; Tsai MM; Yeh CT; Wu CH; Hsieh CC; Wang LH; Chen WJ; Lin KH
Oncogene; 2020 Sep; 39(37):5933-5949. PubMed ID: 32753649
[TBL] [Abstract] [Full Text] [Related]
3. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
[TBL] [Abstract] [Full Text] [Related]
4. Recent Advances in Pathology: the 2020 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Coates PJ
J Pathol; 2020 Apr; 250(5):475-479. PubMed ID: 32346919
[TBL] [Abstract] [Full Text] [Related]
5. Trk inhibitor GNF‑5837 suppresses the tumor growth, survival and migration of renal cell carcinoma.
Chen Y; Wang H; Chen Y; Wang M; Ding G; Li T
Oncol Rep; 2019 Nov; 42(5):2039-2048. PubMed ID: 31485624
[TBL] [Abstract] [Full Text] [Related]
6. Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma.
Hagiwara N; Watanabe M; Iizuka-Ohashi M; Yokota I; Toriyama S; Sukeno M; Tomosugi M; Sowa Y; Hongo F; Mikami K; Soh J; Fujito A; Miyashita H; Morioka Y; Miki T; Ukimura O; Sakai T
Cancer Lett; 2018 Sep; 431():182-189. PubMed ID: 29778569
[TBL] [Abstract] [Full Text] [Related]
7. Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.
Joshi S; Singh AR; Durden DL
Cancer Chemother Pharmacol; 2015 Mar; 75(3):595-608. PubMed ID: 25578041
[TBL] [Abstract] [Full Text] [Related]
8. Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.
Martínez-Montemayor MM; Otero-Franqui E; Martinez J; De La Mota-Peynado A; Cubano LA; Dharmawardhane S
Clin Exp Metastasis; 2010 Oct; 27(7):465-80. PubMed ID: 20517637
[TBL] [Abstract] [Full Text] [Related]
9. A p120 catenin isoform switch affects Rho activity, induces tumor cell invasion, and predicts metastatic disease.
Yanagisawa M; Huveldt D; Kreinest P; Lohse CM; Cheville JC; Parker AS; Copland JA; Anastasiadis PZ
J Biol Chem; 2008 Jun; 283(26):18344-54. PubMed ID: 18407999
[TBL] [Abstract] [Full Text] [Related]
10. The survival kinase Mirk/dyrk1B is activated through rac1-MKK3 signaling.
Jin K; Lim S; Mercer SE; Friedman E
J Biol Chem; 2005 Dec; 280(51):42097-105. PubMed ID: 16257974
[TBL] [Abstract] [Full Text] [Related]
11. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract] [Full Text] [Related]
